Brian McKelligon, President/CEO at Akoya Biosciences, Inc. (AKYA), sold 5,000 shares at $9.92 ($46K) on 2023-03-14, disclosed to the SEC on 2023-03-16.
Scheduled sale ($46k) by President/CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.14 | 4,774 | $44K | 95.1% |
| 2 | $9.92 | 226 | $2K | 4.9% |
| Total | $9.18 avg | 5,000 | $46K | 100% |
| Filing → |
| AKYA | SELL | 2024-03-22 | $37K | — | Filing → |
| AKYA | SELL | 2024-03-22 | $37K | — | Filing → |
| AKYA | SELL | 2023-12-20 | $34K | — | Filing → |